Certain of our investees’ partnership and operating agreements contain terms that, upon the occurrence of specified events, could obligate us to purchase some or all of the noncontrolling interests related to our consolidated subsidiaries. The noncontrolling interests subject to these provisions, and the income available to those interests, are not included as part of our equity and are presented as redeemable noncontrolling interests in the accompanying Condensed Consolidated Balance Sheets at June 30, 2026 and December 31, 2025.

The following table presents the changes in redeemable noncontrolling interests in equity of consolidated subsidiaries:


	Six Months Ended June 30,
	2026		2025
Balances at beginning of period	$	2,956	$	2,727
Net income	224		250
Distributions paid to noncontrolling interests	(245)		(202)

Purchases and sales of businesses and noncontrolling interests, net	(792)		51

Balances at end of period	$	2,143	$	2,826

As previously discussed, we redeemed CHI’s minority equity interest in Conifer effective January 1, 2026. This redemption resulted in an $846 million decrease in our redeemable noncontrolling interests balance and a $306 million increase in our additional paid-in capital balance. See Note 1 for additional information regarding this transaction.

The following tables present the composition by segment of our redeemable noncontrolling interests balances, as well as our net income available to redeemable noncontrolling interests:


	June 30, 2026		December 31, 2025
Hospital Operations	$	47	$	905
Ambulatory Care	2,096		2,051
Redeemable noncontrolling interests	$	2,143	$	2,956


	Six Months Ended June 30,
	2026		2025
Hospital Operations	$	(1)	$	54
Ambulatory Care	225		196
Net income available to redeemable noncontrolling interests	$	224	$	250